Hudson HM - Search Results

1

Combining components of quality of life to increase precision and evaluate trade-offs.

Lumley T, Simes RJ, Gebski V, Hudson HM. Lumley T, et al. Among authors: hudson hm. Stat Med. 2001 Nov 15;20(21):3231-49. doi: 10.1002/sim.1035. Stat Med. 2001. PMID: 11746315

2

Semiparametric methods for multistate survival models in randomised trials.

Hudson HM, Lô SN, Simes RJ, Tonkin AM, Heritier S. Hudson HM, et al. Stat Med. 2014 May 10;33(10):1621-45. doi: 10.1002/sim.6060. Epub 2013 Dec 13. Stat Med. 2014. PMID: 24338893

3

Preliminary validation of an optimally weighted patient-based utility index by application to randomized trials in breast cancer.

Grimison PS, Simes RJ, Hudson HM, Stockler MR. Grimison PS, et al. Among authors: hudson hm. Value Health. 2009 Sep;12(6):967-76. doi: 10.1111/j.1524-4733.2009.00536.x. Epub 2009 Mar 16. Value Health. 2009. PMID: 19490566 Free article.

4

Deriving a patient-based utility index from a cancer-specific quality of life questionnaire.

Grimison PS, Simes RJ, Hudson HM, Stockler MR. Grimison PS, et al. Among authors: hudson hm. Value Health. 2009 Jul-Aug;12(5):800-7. doi: 10.1111/j.1524-4733.2009.00505.x. Value Health. 2009. PMID: 19508665 Free article.

5

Performance of four published risk models to predict sentinel lymph-node involvement in Australian women with early breast cancer.

Elmadahm A, Lord SJ, Hudson HM, Lee CK, Buizen L, Farshid G, Gebski VJ, Gill PG. Elmadahm A, et al. Among authors: hudson hm. Breast. 2018 Oct;41:82-88. doi: 10.1016/j.breast.2018.05.011. Epub 2018 Jun 26. Breast. 2018. PMID: 30007272 Clinical Trial.

6

The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy.

Tjokrowidjaja A, Goldstein D, Hudson HM, Lord SJ, Gebski V, Clarke S, de Souza P, Motzer RJ, Lee CK. Tjokrowidjaja A, et al. Among authors: hudson hm. Acta Oncol. 2020 Jan;59(1):20-27. doi: 10.1080/0284186X.2019.1656342. Epub 2019 Aug 29. Acta Oncol. 2020. PMID: 31462137 Free PMC article.

7

Assessment of NICE and USPSTF guidelines for identifying women at high risk of pre-eclampsia for tailoring aspirin prophylaxis in pregnancy: An individual participant data meta-analysis.

Al-Rubaie ZTA, Askie LM, Hudson HM, Ray JG, Jenkins G, Lord SJ. Al-Rubaie ZTA, et al. Among authors: hudson hm. Eur J Obstet Gynecol Reprod Biol. 2018 Oct;229:159-166. doi: 10.1016/j.ejogrb.2018.08.587. Epub 2018 Sep 2. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 30199814

8

Prediction of pre-eclampsia in nulliparous women using routinely collected maternal characteristics: a model development and validation study.

Al-Rubaie ZTA, Hudson HM, Jenkins G, Mahmoud I, Ray JG, Askie LM, Lord SJ. Al-Rubaie ZTA, et al. Among authors: hudson hm. BMC Pregnancy Childbirth. 2020 Jan 6;20(1):23. doi: 10.1186/s12884-019-2712-x. BMC Pregnancy Childbirth. 2020. PMID: 31906891 Free PMC article.

9

The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review.

Al-Rubaie Z, Askie LM, Ray JG, Hudson HM, Lord SJ. Al-Rubaie Z, et al. Among authors: hudson hm. BJOG. 2016 Aug;123(9):1441-52. doi: 10.1111/1471-0528.14029. Epub 2016 May 26. BJOG. 2016. PMID: 27225348 Review.

10

Patterns of retreatment by radiotherapy.

Barton MB, Hudson HM, Delaney G, Gruver P, Liu Z. Barton MB, et al. Among authors: hudson hm. Clin Oncol (R Coll Radiol). 2011 Feb;23(1):10-8. doi: 10.1016/j.clon.2010.09.013. Epub 2010 Oct 25. Clin Oncol (R Coll Radiol). 2011. PMID: 20980137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters